Haematologist. Lover of haemostasis, thrombosis and obstetrics. Ocean swimmer and amateur runner.
Joined October 2021
- Tweets497
- Following210
- Followers143
- Likes531
Katherine Creeper retweeted
Assessment based on AA alone is insufficient to study aspirin efficacy. A multiagonist approach improves detection of residual reactivity and identifies thromboxane A2-dependent and -independent HARPR. Read in Blood VTH: ow.ly/R5Al50ZUGJK
Katherine Creeper retweeted
🫁 To anticoagulate or not to anticoagulate? Subsegmental PE remains a clinical challenge!
📖 doi.org/10.1016/j.jtha.2026.…
@MarcCarrier1 @grelegal @JTHjournal #VTE
Katherine Creeper retweeted
New RIETE data: women with estrogen-associated VTE have a low risk of recurrence after stopping anticoagulation, but bleeding—particularly uterine bleeding—remains a concern during treatment.
#RIETE #VTE #WomensHealth
Katherine Creeper retweeted
NEW DEFINITIONS for IRON DEFICIENCY delighted to be in the USA with the new American association of haematology guidelines on iron deficiency released - hopefully more women will get the treatment they need
Katherine Creeper retweeted
Extremely excited to share that the @ASH_hematology guidelines on Diagnosis of Iron Deficiency has been released together with toolkits for implementation and teaching slides for education. See below 👇
hematology.org/education/cli…
Katherine Creeper retweeted
According to the latest MBRRACE report, blood clots (VTE) remain the leading cause of maternal death in the UK.
Thrombosis UK is calling for an urgent update the clinical guidance, to help ensure that pregnant women receive the best possible care.
🔗 npeu.ox.ac.uk/mbrrace-uk/rep…
#TUK
Katherine Creeper retweeted
Thrombosis UK welcomes the RCOG's interim changes to improve consistency in practice. However, interim measures are no substitute for comprehensive, up-to-date guidance.
🔗 Learn more here: thrombosisuk.org/pregnancy-h…
#BloodClots #ThrombosisUK
Katherine Creeper retweeted
🆕 📣Check out the latest publication from my #BantingCanada🇨🇦 postdoc fellowship out in @TheLancet #OBGYN! We highlight the population attributable fraction of progestin-only contraception use for #VenousThrombeembolsim.
thelancet.com/journals/lanog…
Katherine Creeper retweeted
Rethinking Bleeding Risk in Patients on Anticoagulation - Danny Hsu (@drdannyhsu )
@DebSiegal | @AndreZimerman | @MarcCarrier1 | @ceciliabahit | @BrianBergmark
hemostasistoday.com/science/…
#HemostasisToday
Please consider supporting my nephew in this fabulous cause!! 🙏🏻
Big or small, every donation counts to help beat blood cancer and I would love your support. worldsgreatestshave.com/s/37…
Katherine Creeper retweeted
CML disease events (loss of MMR/CCR) occurred in 4% of the pregnancies, all of which were reversible upon postpartum TKI resumption. Read the full study in Blood Global Hematology: ow.ly/Ma7650ZoZby #CML
Katherine Creeper retweeted
How long should you treat venous thromboembolism (VTE)? Not simply 3–6 months or indefinitely. The challenge is balancing the risks of recurrent clots and bleeding.
Our 2 new JTH papers provide complementary dynamic risk prediction tools supporting personalised treatment decision
Katherine Creeper retweeted
Antidotes for Anticoagulation Reversal | New England Journal of Medicine by @BiancaRoccaTwt and Hugo ten Cate nejm.org/doi/full/10.1056/ne…
Katherine Creeper retweeted
In patients with pulmonary embolism, ultrasound-facilitated, catheter-directed fibrinolysis led to a lower risk of a composite of major adverse outcomes than anticoagulation alone. Full HI-PEITHO trial results and Research Summary: nej.md/4uMu4lv
ALT The image is from a Research Summary published in the New England Journal of Medicine about catheter-directed fibrinolysis for pulmonary embolism. It includes data on 544 adult patients with an average age of 58. The study compares an intervention group receiving ultrasound-facilitated, catheter-directed fibrinolysis with alteplase and anticoagulation (273 patients) and a control group receiving anticoagulation alone (271 patients). Illustrations show medical devices and a diagram of the lungs.
Katherine Creeper retweeted
Similar ICH rates were observed for patients treated with DOACs and LMWH. No major ICH were observed in patients receiving DOACs. Read in Blood VTH: ow.ly/ahFg50YV7xi
Katherine Creeper retweeted
1/14
Why can't you use direct oral anticoagulants (DOACs) in patients with mechanical valves (MVs)?
DOACs have been one of the most important advances in my career. And yet, the presence of a MV is one of the few contraindications.
The reason highlights the unique nature of thrombus formation in those with a MV and provides insights into the evolution of human hemostasis.
Katherine Creeper retweeted
Cancer & #CVD share overlapping risk factors & biologic pathways, creating opportunities for integrated prevention. Inflammation, oxidative stress, epigenetic dysregulation & clonal hematopoiesis help drive both diseases jacc.org/doi/10.1016/j.jacca… #JACCCardioOnc #cvPrev @LAlhuneafat
Katherine Creeper retweeted
Viscoelastic testing of whole blood identifies delayed clot formation and altered fibrinolysis. ROTEM parameters discriminate patients with BDUC vs healthy controls well but do not predict bleeding severity or bleeding risk. Read in Blood VTH: ow.ly/16ab50YV64U
